AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
Company Description
Treace Medical Concepts, Inc., an orthopedic medical device company, engages in the design, manufacture, and marketing of medical devices for foot and ankle surgeons in the United States.
It offers Lapiplasty procedure that allows podiatric surgeons to treat all three dimensions of the bunion, providing patients with a cosmetic and medical improvement.
The company also provides Lapiplasty Mini-Incision precision system.
In addition, it offers products to address ancillary surgical procedures, including akin osteotomies, weil osteotomies, intercuneiform stabilization, lesser tarsometatarsal joint fusions, and autograft bone harvesting, as well as for MTP fusion.
Treace Medical Concepts, Inc. was founded in 2013 and is headquartered in Ponte Vedra Beach, Florida.
Country | United States |
IPO Date | Apr 23, 2021 |
Industry | Medical - Devices |
Sector | Healthcare |
Employees | 516 |
CEO | John T. Treace |
Contact Details
Address: 203 Fort Wade Road Ponte Vedra, Florida United States | |
Website | https://www.treace.com |
Stock Details
Ticker Symbol | TMCI |
Exchange | NASDAQ |
Fiscal Year | January - December |
Reporting Currency | USD |
CIK Code | 0001630627 |
CUSIP Number | 89455T109 |
ISIN Number | US89455T1097 |
Employer ID | 47-1052611 |
SIC Code | 3841 |
Key Executives
Name | Position |
---|---|
John T. Treace | Chief Executive Officer, Founder & Director |
Mark L. Hair CPA | Chief Financial Officer |
Taylor Erickson | Chief Information Officer |
Aaron J. Berutti | Senior Vice President of Sales |
Daniel E. Owens | Chief Human Resources Officer |
Dr. Sean F. Scanlan Ph.D. | Chief Innovation Officer |
Nathan Minnich | Senior Vice President of Marketing |
Scot M. Elder J.D. | Chief Legal & Compliance Officer and Corporate Secretary |
Shana Zink | Senior Vice President of Clinical Affairs & Reimbursement |
Terry W. Lubben | Chief Operations & Supply Chain Officer |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Dec 05, 2024 | 4 | Filing |
Dec 05, 2024 | 3 | Filing |
Nov 14, 2024 | SC 13G | Statement of acquisition of beneficial ownership b... |
Nov 13, 2024 | 4 | Filing |
Nov 12, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
Nov 08, 2024 | SC 13G | Statement of acquisition of beneficial ownership b... |
Nov 07, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
Nov 05, 2024 | 10-Q | Quarterly Report |
Nov 05, 2024 | 8-K | Current Report |
Nov 04, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |